January 28, 2025
Low-dose aspirin reduced colorectal cancer (CRC) recurrence rates by more than half in patients with tumors harboring mutations in the PI3K signaling pathway, according to findings […]
January 28, 2025
Last year, Eric Singhi, MD, a thoracic medical oncologist at MD Anderson Cancer Center in Houston, noticed a shift in his team. The small band of […]
January 27, 2025
TOPLINE: Fewer than half of patients testing positive for HPV received recommended annual follow-up testing, a new cohort study found. Healthcare systems should track surveillance rates […]
January 27, 2025
A novel treatment approach combining neoadjuvant immunotherapy with chemoradiation showed promising results in patients with locally advanced esophageal squamous cell carcinoma (ESCC), according to preliminary findings […]
January 27, 2025
Adding the somatostatin analog lanreotide to the mTOR inhibitor everolimus significantly prolonged progression-free survival in patients with unresectable or recurrent gastroenteropancreatic neuroendocrine tumors compared with everolimus […]
January 27, 2025
TOPLINE: Adding daratumumab to lenalidomide maintenance therapy after transplant in patients with multiple myeloma triples the minimal residual disease (MRD)–negative conversion rate to 50.5% vs 18.8% […]
January 24, 2025
This week, the Trump administration imposed a range of restrictions that impact the National Institutes of Health (NIH). These include sudden meeting cancellations, such as expert […]
January 24, 2025
SAN ANTONIO — Can breast cancer screening be better tailored to a person’s individual risk of cancer? Guidelines advise heightened surveillance in certain women, including those […]
January 24, 2025
TOPLINE: Adjuvant combination leucovorin calcium, fluorouracil, irinotecan hydrochloride, and oxaliplatin (FOLFIRINOX) and other multiagent chemotherapy regimens boost overall survival (OS) in patients with resected pancreatic adenocarcinoma […]